FINWIRES · TerminalLIVE
FINWIRES

Joincare Pharmaceutical Gets Nod for JKN2501 for Injection's Clinical Trials

By

Joincare Pharmaceutical (SHA:600380) received approval from China's National Medical Products Administration for the clinical trials of JKN2501 for injection, according to a Shanghai bourse disclosure on Thursday.

The drug, which inhibits bacterial β-lactamases, can be applied as a treatment for severe pneumonia, complicated urinary tract infections and other high-incidence infections.

The drug, in combination with meropenem, is currently undergoing phase I clinical trials as a treatment for urinary tract infections.

The pharmaceutical company invested 14.7 million yuan for the research and development of the drug.

Related Articles

Asia

Uranium Producers Rise as New South Wales Uranium Bill Passes into Law

Shares of Australia-listed uranium producers rose in recent Thursday trade as the New South Wales Uranium Bill was passed into law on Monday, according to a Thursday statement by the Minerals Council of Australia.Shares of Deep Yellow (ASX:DYL) rose 5%, while Paladin Energy (ASX:PDN) gained 7% and Nexgen Energy (ASX:NXG) added 6%.The new legislation removes the NSW prohibitions on uranium mining and nuclear energy, according to the statement.

ASX:DYLASX:NXGASX:PDN
Asia

Zeotech Starts Air-Core Drilling at Queensland Project

Zeotech (ASX:ZEO) started a new air-core drilling program at the Toondoon project in Queensland, with 119 holes covering 3,500 meters, according to a Thursday filing with the Australian bourse.The program, designed to increase confidence in the project's mineral resource, will focus on infill grade control drilling on mining lease 80126 and step-out exploration targeting high-prospect areas across exploration permits 27395 and 27866, the filing said.

ASX:ZEO
Asia

China to Issue Treasury Bonds Amounting to 84 Billion Yuan in Hong Kong

China's Ministry of Finance plans to issue 84 billion yuan in treasury bonds in Hong Kong this year, the ministry said in a Wednesday disclosure.The renminbi-denominated treasury bonds in Hong Kong for this year are higher than the 68 billion yuan issued a year earlier, Xinhua reported on the same day.The bonds for this year will be issued in six tranches, with the first two amounting to 29.5 billion yuan already issued in February and April, according to the ministry.

Shanghai Composite^SZSE